Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.
Open Access
- 1 August 1995
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 182 (2), 367-377
- https://doi.org/10.1084/jem.182.2.367
Abstract
Programmed cell death (PCD) is a physiological process commonly defined by alterations in nuclear morphology (apoptosis) and/or characteristic stepwise degradation of chromosomal DNA occurring before cytolysis. However, determined characteristics of PCD such as loss in mitochondrial reductase activity or cytolysis can be induced in enucleated cells, indicating cytoplasmic PCD control. Here we report a sequential disregulation of mitochondrial function that precedes cell shrinkage and nuclear fragmentation. A first cyclosporin A-inhibitable step of ongoing PCD is characterized by a reduction of mitochondrial transmembrane potential, as determined by specific fluorochromes (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine++ + iodide; 3,3'dihexyloxacarbocyanine iodide). Cytofluorometrically purified cells with reduced mitochondrial transmembrane potential are initially incapable of oxidizing hydroethidine (HE) into ethidium. Upon short-term in vitro culture, such cells acquire the capacity of HE oxidation, thus revealing a second step of PCD marked by mitochondrial generation of reactive oxygen species (ROS). This step can be selectively inhibited by rotenone and ruthenium red yet is not affected by cyclosporin A. Finally, cells reduce their volume, a step that is delayed by radical scavengers, indicating the implication of ROS in the apoptotic process. This sequence of alterations accompanying early PCD is found in very different models of apoptosis induction: glucocorticoid-induced death of lymphocytes, activation-induced PCD of T cell hybridomas, and tumor necrosis factor-induced death of U937 cells. Transfection with the antiapoptotic protooncogene Bcl-2 simultaneously inhibits mitochondrial alterations and apoptotic cell death triggered by steroids or ceramide. In vivo injection of fluorochromes such as 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide; 3,3'dihexyloxacarbocyanine iodide; or HE allows for the detection of cells that are programmed for death but still lack nuclear DNA fragmentation. In particular, assessment of mitochondrial ROS generation provides an accurate picture of PCD-mediated lymphocyte depletion. In conclusion, alterations of mitochondrial function constitute an important feature of early PCD.Keywords
This publication has 63 references indexed in Scilit:
- Pharmacological inhibition of programmed lymphocyte deathImmunology Today, 1994
- Mitochondrial respiratory chain inhibitors induce apoptosisFEBS Letters, 1994
- Induction of apoptosis in childhood acute leukemia by chemotherapeutic agents: Failure to detect evidence of apoptosis in vivoEuropean Journal of Haematology, 1994
- Phagocyte recognition of cells undergoing apoptosisImmunology Today, 1993
- Pro‐oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesisFEBS Letters, 1993
- ApoptosisImmunology Today, 1993
- A fluorescence-microscopic and flow-cytometric study of HeLa cells with an experimentally induced respiratory deficiencyBiochemical and Biophysical Research Communications, 1992
- 10-N Nonyl-Acridine Orange: A fluorescent probe which stains mitochondria independently of their energetic stateBiochemical and Biophysical Research Communications, 1989
- Inhibition of mitochondrial protein synthesis influences the glucocorticoid sensitivity of lymphoid cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Superoxide generation by the respiratory chain of tumor mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1987